Feb 01, 2021
Kadimastem Announces Executive Management Changes
Dec 15, 2020
Kadimastem Announces Encouraging Results of Cohort B of its Phase 1/2a Clinical Trial of AstroRx® for ALS
Aug 03, 2020
Kadimastem Reports Positive Interim Results of Cohort B of its AstroRx® Phase 1/2a Clinical Trial in ALS
Jan 06, 2020
Kadimastem Announces Promising Results of Cohort A of its Phase 1/2a Clinical Trial in ALS
Dec 23, 2019
Kadimastem Announces the Completion of Treatment for Cohort B of Its Phase 1/2a Clinical Trial in ALS Patients
Nov 19, 2019
Kadimastem Announces Successful Preclinical Results of Its Cell Therapy Treatment for Insulin-dependent Diabetes
Nov 18, 2019
Kadimastem Intends to Submit an Amendment of its ALS Phase 1/2a Clinical Trial Protocol Following Recent Positive Interim Results
Nov 11, 2019
Kadimastem to Present Interim Results of Cohort A of Its Phase 1/2a Clinical Trial in ALS at the 7th International Stem Cell Meeting, in Tel-Aviv, Israel
Sep 24, 2019
Kadimastem Announces Promising Interim Results of Cohort A of Its Phase 1/2a Clinical Trial in ALS
Jun 03, 2019
Frost & Sullivan Publishes Q1 Update on Kadimastem
May 29, 2019
Kadimastem Announces Leadership Changes
Feb 27, 2019
Kadimastem Announces the Completion of Cell Transplantation of AstroRx® in ALS Patients for Cohort A in Phase I/IIa of Its Clinical Trial
Nov 12, 2018
Kadimastem and Defymed Awarded Grant in the EU's Prestigious Eurostars Program for the Clinical Development of an Integrated Product for the Treatment of Diabetes
Oct 09, 2018
Medical Breakthrough on a Global Scale and Significant Achievement for Kadimastem
Oct 02, 2018
Altshuler Shaham and Company Stakeholders Lead $5.15 Million Investment in Kadimastem
Jul 02, 2018
Kadimastem and The Australian Foundation for Diabetes Research (AFDR) Selected to Receive a Bi-National Grant from the Australian Government and the Israel Innovation Authority to Explore a Combined Diabetes Solution
Jun 06, 2018
Scientific Article by Kadimastem Regarding Its Cell-Based Treatment for ALS Published by a Prestigious Cell Therapy Scientific Journal
Apr 26, 2018
Kadimastem Announces the Enrollment of the First Patient for Its Clinical Trial in ALS Patients
Mar 13, 2018
New Hope for ALS Patients Worldwide: Kadimastem Commences Its Clinical Trial in ALS Patients at Hadassah Medical Center After it Received Approval From the Ministry of Health
Aug 14, 2017
A Vote of Confidence in Kadimastem: Senior Scientists from the Weizmann Institute Invest in the Company